DK1408038T3 - Imidazolderivater samt deres anvendelse som perifert selektive inhibitorer dopamin-beta-hydroxylase - Google Patents
Imidazolderivater samt deres anvendelse som perifert selektive inhibitorer dopamin-beta-hydroxylaseInfo
- Publication number
- DK1408038T3 DK1408038T3 DK03256420T DK03256420T DK1408038T3 DK 1408038 T3 DK1408038 T3 DK 1408038T3 DK 03256420 T DK03256420 T DK 03256420T DK 03256420 T DK03256420 T DK 03256420T DK 1408038 T3 DK1408038 T3 DK 1408038T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxylase
- selective inhibitors
- imidazole derivatives
- dopamine beta
- peripherally selective
- Prior art date
Links
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title 1
- 229940124639 Selective inhibitor Drugs 0.000 title 1
- 150000002460 imidazoles Chemical class 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0223719A GB2393958A (en) | 2002-10-11 | 2002-10-11 | Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase |
| GB0224306A GB2394223B (en) | 2002-10-11 | 2002-10-18 | Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1408038T3 true DK1408038T3 (da) | 2008-11-24 |
Family
ID=9945777
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03256420T DK1408038T3 (da) | 2002-10-11 | 2003-10-10 | Imidazolderivater samt deres anvendelse som perifert selektive inhibitorer dopamin-beta-hydroxylase |
| DK07076125.9T DK1908760T3 (da) | 2002-10-11 | 2003-10-10 | Chroman- og thiochroman-3-yl-1,3-dihydroimidazoler som inhibitorer af dopamin-beta-hydroxylase og fremgangsmåder til deres fremstilling |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07076125.9T DK1908760T3 (da) | 2002-10-11 | 2003-10-10 | Chroman- og thiochroman-3-yl-1,3-dihydroimidazoler som inhibitorer af dopamin-beta-hydroxylase og fremgangsmåder til deres fremstilling |
Country Status (10)
| Country | Link |
|---|---|
| KR (1) | KR101350741B1 (de) |
| CN (1) | CN100393715C (de) |
| AR (2) | AR041589A1 (de) |
| AT (5) | ATE403652T1 (de) |
| CY (2) | CY1108452T1 (de) |
| DE (4) | DE60336276D1 (de) |
| DK (2) | DK1408038T3 (de) |
| ES (5) | ES2364919T3 (de) |
| GB (2) | GB2393958A (de) |
| SI (2) | SI1408038T1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0708818D0 (en) * | 2007-05-08 | 2007-06-13 | Portela & Ca Sa | Compounds |
| PT2655363T (pt) * | 2010-12-22 | 2017-07-13 | Bial-Portela & Ca S A | Formas cristalinas e processos para a sua preparação |
| GB201316410D0 (en) * | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL82401A0 (en) * | 1986-05-06 | 1987-11-30 | Merrell Dow Pharma | Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| ES2201104T3 (es) * | 1994-04-26 | 2004-03-16 | Roche Palo Alto Llc | Derivados de benzociclohexilimidazoltiona. |
-
2002
- 2002-10-11 GB GB0223719A patent/GB2393958A/en not_active Withdrawn
- 2002-10-18 GB GB0224306A patent/GB2394223B/en not_active Expired - Lifetime
-
2003
- 2003-10-10 AR ARP030103711A patent/AR041589A1/es active IP Right Grant
- 2003-10-10 DK DK03256420T patent/DK1408038T3/da active
- 2003-10-10 AT AT03256420T patent/ATE403652T1/de active
- 2003-10-10 DE DE60336276T patent/DE60336276D1/de not_active Expired - Lifetime
- 2003-10-10 SI SI200331309T patent/SI1408038T1/sl unknown
- 2003-10-10 DK DK07076125.9T patent/DK1908760T3/da active
- 2003-10-10 DE DE60336275T patent/DE60336275D1/de not_active Expired - Lifetime
- 2003-10-10 ES ES07076125T patent/ES2364919T3/es not_active Expired - Lifetime
- 2003-10-10 ES ES07076123T patent/ES2384118T3/es not_active Expired - Lifetime
- 2003-10-10 AT AT07076123T patent/ATE550335T1/de active
- 2003-10-10 ES ES07076122T patent/ES2361938T3/es not_active Expired - Lifetime
- 2003-10-10 KR KR1020127005102A patent/KR101350741B1/ko not_active Expired - Fee Related
- 2003-10-10 DE DE60322642T patent/DE60322642D1/de not_active Expired - Lifetime
- 2003-10-10 ES ES07076124T patent/ES2361939T3/es not_active Expired - Lifetime
- 2003-10-10 ES ES03256420T patent/ES2309279T3/es not_active Expired - Lifetime
- 2003-10-10 AT AT07076124T patent/ATE500247T1/de not_active IP Right Cessation
- 2003-10-10 AT AT07076125T patent/ATE505465T1/de active
- 2003-10-10 CN CNB2003801059426A patent/CN100393715C/zh not_active Expired - Fee Related
- 2003-10-10 SI SI200331986T patent/SI1908760T1/sl unknown
- 2003-10-10 AT AT07076122T patent/ATE500248T1/de not_active IP Right Cessation
- 2003-10-10 DE DE60336772T patent/DE60336772D1/de not_active Expired - Lifetime
-
2008
- 2008-10-24 CY CY20081101204T patent/CY1108452T1/el unknown
-
2011
- 2011-07-01 CY CY20111100639T patent/CY1112457T1/el unknown
-
2014
- 2014-03-18 AR ARP140101283A patent/AR095674A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR095674A2 (es) | 2015-11-04 |
| GB2393958A (en) | 2004-04-14 |
| ES2309279T3 (es) | 2008-12-16 |
| ES2364919T3 (es) | 2011-09-16 |
| CY1108452T1 (el) | 2014-04-09 |
| ATE500247T1 (de) | 2011-03-15 |
| DK1908760T3 (da) | 2011-07-25 |
| KR101350741B1 (ko) | 2014-01-10 |
| ATE403652T1 (de) | 2008-08-15 |
| CN100393715C (zh) | 2008-06-11 |
| CY1112457T1 (el) | 2015-12-09 |
| GB2394223B (en) | 2007-05-16 |
| SI1408038T1 (sl) | 2008-10-31 |
| ES2384118T3 (es) | 2012-06-29 |
| DE60336276D1 (de) | 2011-04-14 |
| CN1726211A (zh) | 2006-01-25 |
| DE60336275D1 (de) | 2011-04-14 |
| SI1908760T1 (sl) | 2011-05-31 |
| ATE505465T1 (de) | 2011-04-15 |
| ES2361939T3 (es) | 2011-06-24 |
| GB0224306D0 (en) | 2002-11-27 |
| GB2394223A (en) | 2004-04-21 |
| GB0223719D0 (en) | 2002-11-20 |
| DE60322642D1 (de) | 2008-09-18 |
| DE60336772D1 (de) | 2011-05-26 |
| HK1116188A1 (en) | 2008-12-19 |
| ATE500248T1 (de) | 2011-03-15 |
| AR041589A1 (es) | 2005-05-26 |
| KR20120038014A (ko) | 2012-04-20 |
| ES2361938T3 (es) | 2011-06-24 |
| ATE550335T1 (de) | 2012-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC1482932I2 (lt) | N3 alkilinto benzimidazolo dariniai kaip MEK inhibitoriai | |
| CY2016042I2 (el) | Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων | |
| NO20050426L (no) | Arylkarbonylderivater som terapeutiske midler | |
| DK1478629T3 (da) | N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler | |
| NO20053215D0 (no) | Pyrazolderivater med anvendelse som COX-1-inhibitorer. | |
| DK1527050T3 (da) | Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer | |
| DK1663232T3 (da) | Benzimidazolderivater som human chymase-inhibitorer | |
| IS7667A (is) | Nýjar bensimídazólafleiður | |
| DK1492785T3 (da) | 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer | |
| DE60329601D1 (de) | Benzothiazolderivate mit beta-2-adrenorezeptor-agonistenwirkung | |
| DK1585749T3 (da) | Diazepinoindol-derivater som kinaseinhibitorer | |
| NO20051236L (no) | Heterobiarylderivater som matriksmetalloproteinaseinhibitorer | |
| DK1789041T3 (da) | Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer | |
| IS8384A (is) | Alkýleraðar bensímídasólafleiður sem MEK-hindrar | |
| ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
| DK1551802T3 (da) | Indol-3-svovlderivater | |
| ATE467631T1 (de) | Chinuclidinamidderivate | |
| ATE438644T1 (de) | Chinazolinderivate | |
| IS7720A (is) | Píperidín-N-oxíð-afleiður | |
| DK1474408T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
| DK1648426T3 (da) | Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer | |
| NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
| DK1797042T3 (da) | Indozolonderivater som 11B-HSD1-inhibitorer | |
| NO20043950L (no) | 3-cyklyl -5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler | |
| ATE529428T1 (de) | Thioxanthinderivate als myeloperoxidaseinhibitoren |